Cargando…
Selective and Specific Inhibition of I(f) with Ivabradine for the Treatment of Coronary Artery Disease or Heart Failure
Heart rate is an important contributor in the pathophysiology of both coronary artery disease (CAD) and heart failure (HF). Ivabradine is an anti-anginal and anti-ischaemic agent, which selectively and specifically inhibits the I (f) current in the sino-atrial node and provides pure heart rate reduc...
Autor principal: | Deedwania, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786091/ https://www.ncbi.nlm.nih.gov/pubmed/24065301 http://dx.doi.org/10.1007/s40265-013-0117-0 |
Ejemplares similares
-
Ivabradine, coronary artery disease, and heart failure: beyond rhythm control
por: Scicchitano, Pietro, et al.
Publicado: (2014) -
Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives
por: Sattar, Yasar, et al.
Publicado: (2019) -
Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018) -
Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016) -
Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)